Suppr超能文献

最小临床重要差异:临床意义综述

The Minimal Clinically Important Difference: A Review of Clinical Significance.

作者信息

Bloom David A, Kaplan Daniel J, Mojica Edward, Strauss Eric J, Gonzalez-Lomas Guillem, Campbell Kirk A, Alaia Michael J, Jazrawi Laith M

机构信息

NYU Langone Health, New York, New York, USA.

出版信息

Am J Sports Med. 2023 Feb;51(2):520-524. doi: 10.1177/03635465211053869. Epub 2021 Dec 2.

Abstract

BACKGROUND

The minimal clinically important difference (MCID) is a term synonymous with orthopaedic clinical research over the past decade. The term represents the smallest change in a patient-reported outcome measure that is of genuine clinical value to patients. It has been derived in a myriad of ways in existing orthopaedic literature.

PURPOSE

To describe the various modalities for deriving the MCID.

STUDY DESIGN

Narrative review; Level of evidence, 4.

METHODS

The definitions of common MCID determinations were first identified. These were then evaluated by their clinical and statistical merits and limitations.

RESULTS

There are 3 primary ways for determining the MCID: anchor-based analysis, distribution-based analysis, and sensitivity- and specificity-based analysis. Each has unique strengths and weaknesses with respect to its ability to evaluate the patient's clinical status change from baseline to posttreatment. Anchor-based analyses are inherently tied to clinical status yet lack standardization. Distribution-based analyses are the opposite, with strong foundations in statistics, yet they fail to adequately address the clinical status change. Sensitivity and specificity analyses offer a compromise of the other methodologies but still rely on a somewhat arbitrarily defined global transition question.

CONCLUSION

This current concepts review demonstrates the need for (1) better standardization in the establishment of MCIDs for orthopaedic patient-reported outcome measures and (2) better study design-namely, until a universally accepted MCID derivation exists, studies attempting to derive the MCID should utilize the anchor-based within-cohort design based on Food and Drug Administration recommendations. Ideally, large studies reporting the MCID as an outcome will also derive the value for their populations. It is important to consider that there may be reasonable replacements for current derivations of the MCID. As such, future research should consider an alternative threshold score with a more universal method of derivation.

摘要

背景

最小临床重要差异(MCID)是过去十年骨科临床研究中的一个同义词。该术语代表患者报告结局指标中对患者具有真正临床价值的最小变化。在现有骨科文献中,它已通过多种方式得出。

目的

描述得出MCID的各种方法。

研究设计

叙述性综述;证据等级,4级。

方法

首先确定常见MCID测定的定义。然后根据其临床和统计学优点及局限性对这些定义进行评估。

结果

确定MCID有3种主要方法:基于锚定的分析、基于分布的分析以及基于敏感性和特异性的分析。就评估患者从基线到治疗后临床状态变化的能力而言,每种方法都有独特的优缺点。基于锚定的分析本质上与临床状态相关,但缺乏标准化。基于分布的分析则相反,在统计学方面有坚实基础,但未能充分解决临床状态变化问题。敏感性和特异性分析提供了其他方法的折衷,但仍依赖于某种任意定义的总体转变问题。

结论

本次概念性综述表明,需要(1)在为骨科患者报告结局指标建立MCID时更好地实现标准化,以及(2)更好的研究设计——即,在存在普遍接受的MCID推导方法之前,试图推导MCID的研究应根据美国食品药品监督管理局的建议采用基于锚定的队列内设计。理想情况下,将MCID作为结局报告的大型研究也应为其研究人群得出该值。重要的是要考虑到可能存在当前MCID推导方法的合理替代方法。因此,未来的研究应考虑采用更通用的推导方法的替代阈值分数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验